Mortimer Mamelak

2.3k total citations
55 papers, 1.7k citations indexed

About

Mortimer Mamelak is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mortimer Mamelak has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cognitive Neuroscience, 19 papers in Experimental and Cognitive Psychology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mortimer Mamelak's work include Sleep and Wakefulness Research (29 papers), Sleep and related disorders (19 papers) and Neuroscience and Neuropharmacology Research (14 papers). Mortimer Mamelak is often cited by papers focused on Sleep and Wakefulness Research (29 papers), Sleep and related disorders (19 papers) and Neuroscience and Neuropharmacology Research (14 papers). Mortimer Mamelak collaborates with scholars based in Canada and United States. Mortimer Mamelak's co-authors include Roger Broughton, Martin B. Scharf, Roy H. Maffly, Ann Taylor, Jacques Montplaisir, Jed Black, Eve Reaven, A Csima, R. Ristanovic and Peter Williamson and has published in prestigious journals such as Science, The Lancet and Gastroenterology.

In The Last Decade

Mortimer Mamelak

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mortimer Mamelak Canada 22 688 515 426 333 317 55 1.7k
Alan S. Bloom United States 23 954 1.4× 223 0.4× 1.4k 3.2× 545 1.6× 259 0.8× 46 2.4k
David Nutt United Kingdom 29 480 0.7× 387 0.8× 1.3k 3.1× 758 2.3× 219 0.7× 72 2.5k
Jewell W. Sloan United States 17 266 0.4× 104 0.2× 942 2.2× 400 1.2× 313 1.0× 55 1.7k
G J Wang United States 12 558 0.8× 116 0.2× 1.2k 2.8× 447 1.3× 161 0.5× 14 1.9k
Fabio Fadda Italy 23 411 0.6× 71 0.1× 1.7k 4.1× 658 2.0× 282 0.9× 36 2.4k
Christoph Fehr Germany 20 338 0.5× 100 0.2× 630 1.5× 449 1.3× 233 0.7× 45 1.7k
Joanna S. Fowler United States 15 552 0.8× 95 0.2× 1.5k 3.6× 466 1.4× 136 0.4× 18 2.2k
Hee Jin Kim South Korea 24 353 0.5× 67 0.1× 503 1.2× 656 2.0× 168 0.5× 106 1.8k
Massimo Bani Italy 26 402 0.6× 261 0.5× 797 1.9× 431 1.3× 152 0.5× 48 1.7k

Countries citing papers authored by Mortimer Mamelak

Since Specialization
Citations

This map shows the geographic impact of Mortimer Mamelak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mortimer Mamelak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mortimer Mamelak more than expected).

Fields of papers citing papers by Mortimer Mamelak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mortimer Mamelak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mortimer Mamelak. The network helps show where Mortimer Mamelak may publish in the future.

Co-authorship network of co-authors of Mortimer Mamelak

This figure shows the co-authorship network connecting the top 25 collaborators of Mortimer Mamelak. A scholar is included among the top collaborators of Mortimer Mamelak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mortimer Mamelak. Mortimer Mamelak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batchuluun, Battsetseg, et al.. (2022). Prevention of Lipotoxicity in Pancreatic Islets with Gammahydroxybutyrate. Cells. 11(3). 545–545. 5 indexed citations
2.
Mamelak, Mortimer. (2018). Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate. Neurology and Therapy. 7(1). 5–11. 57 indexed citations
4.
Mamelak, Mortimer. (2017). Energy and the Alzheimer brain. Neuroscience & Biobehavioral Reviews. 75. 297–313. 33 indexed citations
5.
Bogan, Richard, Todd J. Swick, Mortimer Mamelak, et al.. (2016). Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial. Neurology and Therapy. 5(2). 203–213. 18 indexed citations
6.
Mamelak, Mortimer, Todd J. Swick, Hélène A. Emsellem, et al.. (2014). A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy. Sleep Medicine. 16(1). 52–58. 17 indexed citations
7.
Mamelak, Mortimer. (2009). Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Progress in Neurobiology. 89(2). 193–219. 44 indexed citations
8.
Guilleminault, Christian, et al.. (2007). A Review of its Use in the Management of Narcolepsy. 1 indexed citations
9.
Mamelak, Mortimer, Jed Black, Jacques Montplaisir, & R. Ristanovic. (2004). A Pilot Study on the Effects of Sodium Oxybate on Sleep Architecture and Daytime Alertness in Narcolepsy. SLEEP. 27(7). 1327–1334. 112 indexed citations
10.
Kolín, A, et al.. (1993). Cardioprotective action of sodium gamma-hydroxybutyrate against isoproterenol induced myocardial damage.. PubMed. 74(3). 275–81. 11 indexed citations
11.
Mamelak, Mortimer. (1991). A model for narcolepsy.. Canadian Journal of Psychology/Revue Canadienne de Psychologie. 45(2). 194–220. 13 indexed citations
12.
Mamelak, Mortimer, et al.. (1990). Clinical Recovery and Sleep Architecture Degradation. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 17(3). 332–335. 20 indexed citations
13.
Boyd, April J., Igor A. Sherman, Fred Saibil, & Mortimer Mamelak. (1990). The protective effect of γ-hydroxybutyrate in regional intestinal ischemia in the hamster. Gastroenterology. 99(3). 860–862. 25 indexed citations
14.
Williamson, Peter, Stan Kutcher, Perry W. Cooper, et al.. (1989). Psychological, topographic EEG, and CT scan correlates of frontal lobe function in schizophrenia. Psychiatry Research. 29(2). 137–149. 48 indexed citations
15.
Mamelak, Mortimer. (1989). Gammahydroxybutyrate: An endogenous regulator of energy metabolism. Neuroscience & Biobehavioral Reviews. 13(4). 187–198. 129 indexed citations
16.
Mamelak, Mortimer, et al.. (1987). Effects of Flurazepam and Zopiclone on the Performance of Chronic Insomniac Patients: A Study of Ethanol-Drug Interaction. SLEEP. 10(suppl_1). 79–87. 14 indexed citations
17.
Mamelak, Mortimer, et al.. (1985). Effects of Quazepam and Triazolam on the Sleep of Chronic Insomniacs: A Comparative 25-Night Sleep Laboratory Study. Clinical Neuropharmacology. 8. S63–S73. 4 indexed citations
18.
Mamelak, Mortimer, et al.. (1983). The effect of gammahydroxy‐butyrate on the H‐reflex. Neurology. 33(11). 1497–1497. 10 indexed citations
19.
Mamelak, Mortimer, et al.. (1979). Narcolepsy: a family study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 14(5). 821–34. 14 indexed citations
20.
Mamelak, Mortimer, Steven L. Wissig, Rita Bogoroch, & I. S. Edelman. (1969). Physiological and morphological effects of poly-L-lysine on the toad bladder. The Journal of Membrane Biology. 1(1). 144–176. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026